H.R. 4811 · 117th Congress
Medicare Negotiation and Competitive Licensing Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DoggettSponsor79 cosponsors · 79 D
D
Blumenauer
JB
D
Bowman
CB
D
Bush
DB
D
Beyer
EC
D
Cleaver
SC
D
Cohen
JC
D
Chu
DC
D
Cicilline
MC
D
Cartwright
JC
D
Castro
PD
D
DeFazio
RD
D
DeLauro
DD
D
Dingell
AE
D
Espaillat
VE
D
Escobar
RG
D
Grijalva
AG
D
Green
JG
D
Garamendi
CG
D
García
SJ
D
Jackson Lee
PJ
D
Jayapal
MK
D
Kaptur
RK
D
Khanna
RK
D
Krishnamoorthi
AK
D
Kim
KK
D
Kahele
TL
D
Leger Fernandez
BL
D
Lee
JL
D
Langevin
AL
D
Lowenthal
AL
D
Levin
KM
D
Mfume
GM
D
Moore
JM
D
McNerney
JN
D
Nadler
EN
D
Norton
JN
D
Neguse
MN
D
Newman
AO
D
Ocasio-Cortez
IO
D
Omar
EP
D
Perlmutter
CP
D
Pingree
MP
D
Pocan
AP
D
Pressley
KP
D
Porter
JR
D
Raskin
BS
D
Sherman
JS
D
Schakowsky
BT
D
Thompson
DT
D
Titus
MT
D
Takano
RT
D
Tlaib
RT
D
Torres
NV
D
Velázquez
FV
D
Vela
MW
D
Waters
JY
D
Yarmuth
SG
D
Garcia
JH
D
Huffman
GN
D
Napolitano
LR
D
Roybal-Allard
MS
D
Scanlon
AA
D
Adams
TL
D
Lieu
AS
D
Schiff
DN
D
Norcross
YC
D
Clarke
MD
D
DeSaulnier
HJ
D
Jeffries
BL
D
Lawrence
KB
D
Bass
SB
D
Brown
LF
D
Frankel
SH
D
Horsford
AS
D
Smith
TC
D
Carter
MJ
D
Jones
RG
D
Gallego
SJ
D
Jacobs57 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill establishes several requirements relating to the prices of prescription drugs.
What it does: CRS summary · Introduced in House · Jul 29, 2021
Medicare Negotiation and Competitive Licensing Act of 2021
This bill establishes several requirements relating to the prices of prescription drugs.
Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under Medicare. (Current law prohibits the CMS from doing so.) If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under health insurance programs, notwithstanding existing government-granted exclusivities.
The negotiated prices also apply to other federal health care programs, private health insurance, and the uninsured; pharmacies that charge more than the negotiated price for uninsured individuals are subject to civil penalties. Manufacturers must also comply with specified reporting requirements relating to prices and licensing, subject to civil penalties.
The bill also institutes an excise tax on drugs for which the price spikes beyond a certain limit, subject to specified exemptions, as well as on drugs for which the price exceeds the negotiated price.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicare Negotiation and Competitive Licensing Act of 2021
Latest action (Sep 8, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jul 29, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.